☆ 4.6 Article

Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation clearances in non-pregnant and pregnant women

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Renal function estimating equations performance during pregnancy and postpartum

Dina E. Zaghloul et al.

Summary: The study aimed to evaluate the performance of renal function estimating equations compared to measured creatinine clearance (CrCl) during pregnancy and postpartum, and to assess which body weight provides the best performance. The results showed that CG (PPW) and CG (ABW) had the best performance during pregnancy and postpartum, respectively. Based on overall performance, CG (PPW) was the best during pregnancy, and 100/SCr was the best postpartum.

PHARMACOTHERAPY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats

Sheena Sharma et al.

Summary: The poor and variable oral bioavailability of furosemide (FUR) is a critical challenge in pharmacotherapy. This study investigated the interplay of breast cancer resistance protein (Bcrp)-mediated transport, sex, and fed state on FUR pharmacokinetics (PK) in rats. The results suggest that the PK of Bcrp and/or Oat substrates could be sex-dependent in rats and that species and sex differences in Bcrp and Oat abundance in the kidney should be considered when scaling rat PK and toxicological data of Bcrp substrates. Furthermore, Bcrp inhibition should be evaluated in prospective clinical studies to assess its effect on FUR PK.

PHARMACEUTICS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References

Giovanni Bocci et al.

Summary: The Biopharmaceutics Drug Disposition Classification system (BDDCS) is a classification system based on water solubility and metabolism/permeability rate, which can predict the role of enzymes and transporters in drug disposition. This article presents the application of BDDCS in 1475 drugs and active metabolites, including revisions of previous classification studies. It also discusses the uses of BDDCS in drug development.

AAPS JOURNAL (2022)

添加到收藏夹

Article Biochemical Research Methods

Development, validation, and implementation of an UHPLC-MS/MS method for the quantitation of furosemide in infant urine samples

Christina Vedar et al.

Summary: An accurate and reliable method for quantitating furosemide in human urine has been developed, demonstrating stability and precision for potential use in pediatric clinical studies.

BIOMEDICAL CHROMATOGRAPHY (2022)

添加到收藏夹

Article Medicine, General & Internal

Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide

Gerd Klinkmann et al.

Summary: This study investigated the efficacy of furosemide in relation to albumin binding and function. The results showed that albumin binding capacity had an impact on the efficacy of furosemide, with higher ABiC associated with lower free furosemide fraction and higher urinary furosemide concentration.

MEDICINA-LITHUANIA (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes

Raju Khatri et al.

Summary: Pregnancy-related hormones have been shown to influence the expression and function of UGT proteins, particularly enhancing UGT1A1-mediated metabolism of labetalol in human hepatocytes. This findings provide mechanistic insight into the increased clearance of labetalol observed in pregnant individuals.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section

Paulo Vinicius Bernardes Goncalves et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide

Revathi Chapa et al.

ACS OMEGA (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Use of Medication for Cardiovascular Disease During Pregnancy JACC State-of-the-Art Review

Dan G. Halpern et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects

Hong Shen et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail

Peter Stopfer et al.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions

Peter Stopfer et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium

Raymond Evers et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

Xiaoyan Chu et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Population pharmacokinetic modeling of furosemide in patients with hypertension and fluid overload conditions

Devender Kodati et al.

PHARMACOLOGICAL REPORTS (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin

P. Stopfer et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)

添加到收藏夹

Review Health Care Sciences & Services

Furosemide

Laura Carone et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)

添加到收藏夹

Article Chemistry, Medicinal

The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical SettingProposal of a Four Component Transporter Cocktail

Thomas Ebner et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2015)

添加到收藏夹

Article Chemistry, Analytical

Rapid UHPLC Method for Simultaneous Determination of Vancomycin, Terbinafine, Spironolactone, Furosemide and Their Metabolites: Application to Human Plasma and Urine

Irena Baranowska et al.

ANALYTICAL SCIENCES (2010)

添加到收藏夹

Article Chemistry, Analytical

Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples

Daniela Iuliana Sora et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway

Oranun Kerdpin et al.

BIOCHEMICAL PHARMACOLOGY (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach

GD Anderson

CLINICAL PHARMACOKINETICS (2005)

添加到收藏夹

Article Biochemical Research Methods

Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry

K Deventer et al.

BIOMEDICAL CHROMATOGRAPHY (2002)

添加到收藏夹

Article Pharmacology & Pharmacy

High-performance liquid chromatography-mass spectrometric analysis of furosemide in plasma and its use in pharmacokinetic studies

ME Abdel-Hamid

FARMACO (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.